Endelige resultater fra CLN-14-studiet i bløddelssarkom
20 nov. 2013 07h45 HE
|
Topotarget
Til NASDAQ OMX Copenhagen A/S
Meddelelse nr. 26-13 / København, 20. november 2013
Topotarget offentliggør de endelige resultater fra det første stadie af fase II-delen af det kliniske fase...
Topotarget announces the financial results for the first 9 months of 2013
07 nov. 2013 03h09 HE
|
Topotarget
To NASDAQ OMX Copenhagen A/S
Announcement no. 25-13 / Copenhagen, November 7, 2013
Topotarget announces that the board of directors has reviewed and approved the company’s interim report for the...
Topotarget offentliggør resultat for de første 9 måneder af 2013
07 nov. 2013 03h09 HE
|
Topotarget
Til NASDAQ OMX Copenhagen A/S
Meddelelse nr. 25-13 / København, 7. november 2013
Topotarget meddeler, at bestyrelsen i dag har behandlet og godkendt selskabets delårsrapport for perioden 1....
Finanskalender 2014
01 nov. 2013 05h44 HE
|
Topotarget
Til NASDAQ OMX Copenhagen A/S
Meddelelse nr. 24-13 / København, 1. november 2013
Topotarget offentliggør hermed selskabets finanskalender for...
Financial Calendar 2014
01 nov. 2013 05h44 HE
|
Topotarget
To NASDAQ OMX Copenhagen A/S
Announcement no. 24-13 / Copenhagen, November 1, 2013
Topotarget announces its financial calendar for 2014 as...
Time and date for teleconference regarding financial results for first 9 months 2013
01 nov. 2013 05h04 HE
|
Topotarget
To NASDAQ OMX Copenhagen A/S
Investor News No. 09-13 / Copenhagen, November 1, 2013 Topotarget A/S
Topotarget announces that a teleconference will be held on November 7, 2013 at 1:00 pm...
Tid og dato for telekonference vedrørende resultat for første 9 måneder 2013
01 nov. 2013 05h04 HE
|
Topotarget
Til NASDAQ OMX Copenhagen A/S
Investor Nyhed nr. 09-13 / København, 1. november 2013 Topotarget A/S
Topotarget meddelte i dag, at der vil blive afholdt en telekonference den 7. november 2013...
Topotarget og Spectrum Pharmaceuticals aftaler vilkårene for kommerciel fremstilling af belinostat
07 oct. 2013 03h01 HE
|
Topotarget
Til NASDAQ OMX Copenhagen A/S
Meddelelse nr. 23-13 / København, 7. oktober 2013
Topotarget og Spectrum Pharmaceuticals offentliggør en ændring til selskabernes eksisterende licensaftale. I...
Topotarget and Spectrum Pharmaceuticals agree on terms for commercial supply of belinostat
07 oct. 2013 03h01 HE
|
Topotarget
To NASDAQ OMX Copenhagen A/S
Announcement no. 23-13 / Copenhagen, October 7, 2013
Topotarget and Spectrum Pharmaceuticals announce an amendment to the companies’ existing License Agreement....
Topotarget to present at the 15th Annual Rodman & Renshaw Global Investment Conference
30 août 2013 08h46 HE
|
Topotarget
To NASDAQ OMX Copenhagen A/S
Investor News No. 08-13 / Copenhagen, August 30, 2013
Topotarget will be presenting at the 15th Annual Rodman & Renshaw Global Investment Conference which is...